Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenues	$ 0	$ 0
OPERATING EXPENSES:
General and administrative expenses	183,083	219,656
Payroll and compensation	168,945	2,056,144
Legal	118,280	0
Research and development	0	91,301
Debt transaction expenses	24,900	110,685
Amortization of patents	51,028	60,839
Total operating expenses	546,236	2,538,625
OPERATING LOSS	(546,236)	(2,538,625)
OTHER INCOME (EXPENSE):
Interest expense	(505,683)	(531,796)
Gain (loss) on convertible notes	(405,386)	206,474
Gain (Loss) on change in fair market values of derivative liabilities	(368,164)	(159,324)
Loss on merger	0	(294,788)
TOTAL OTHER EXPENSES	(1,279,233)	(779,434)
NET LOSS	(1,825,469)	(3,318,059)
Net Loss attributable to noncontrolling interests in variable interest entity and subsidiary	0	0
Net loss attributable to Company stockholders	$ (1,825,469)	$ (3,318,059)
LOSS PER SHARE:
Basic and Diluted	$ (0.00)	$ (0.04)
WEIGHTED AVERAGE SHARES OUTSTANDING:
Basic and Diluted	487,850,346	89,680,567